Exuviance Daily Acne Peel

Description

Exuviance® FOCUS is a daily acne peel specifically formulated for oily and acne-prone skin. This product contains a 2% Salicylic Acid acne solution, which effectively clears blemishes and addresses both blackheads and whiteheads. Additionally, it incorporates Citric Acid and Tartaric Acid to enhance skin texture and reduce oiliness. The formulation is presented in a 100 mL (3.4 fl oz) container, designed for convenient daily use.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris. It effectively clears acne blemishes, including acne pimples, blackheads, and whiteheads. Additionally, it promotes the healing of the skin and helps prevent the formation of new acne blemishes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the medication. The affected area should be covered with a thin layer of the product using a cotton pad. This application should occur 1 to 3 times daily, while avoiding the eye area.

For initial treatment, it is recommended to start with one application per day to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to 2 to 3 times daily, or as directed by a physician. In cases where bothersome peeling or dryness is experienced, the frequency of application should be reduced to once daily or every other day.

For new users, it is advisable to apply the product sparingly to 1 or 2 small affected areas for a duration of approximately 3 days. If no discomfort is noted during this period, the patient may then follow the previously mentioned application guidelines.

After each application, hands should be washed thoroughly to prevent unintentional contact with other areas of the body. Additionally, patients should be advised to avoid sun exposure and to use sunscreen daily to protect the treated areas.

Contraindications

Use is contraindicated in patients who are pregnant or lactating due to potential risks to the fetus or nursing infant. Additionally, the product should not come into contact with the eyes, as this may lead to irritation or other adverse effects.

Warnings and Precautions

For external use only. This product is contraindicated during pregnancy and lactation. Care should be taken to avoid contact with the eyes; in the event of contact, rinse thoroughly with water to remove the product.

When using this product, caution is advised regarding the concurrent use of other topical acne medications. The simultaneous application of multiple treatments may exacerbate skin dryness or irritation. It is recommended that only one topical medication be utilized at a time unless otherwise directed by a healthcare professional.

Patients should discontinue use and consult a physician if they experience excessive skin irritation or increased sensitivity.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is advised.

This product should be stored out of reach of children to prevent accidental ingestion. Additionally, it is important to note that the product is flammable; therefore, it should be kept away from fire or flame to ensure safety.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for use during pregnancy and lactation. Care should be taken to avoid contact with the eyes; in the event of contact, the area should be rinsed with water to remove the product.

When using this product, patients are advised against the concurrent use of other topical acne medications, as this may exacerbate skin dryness or irritation. Only one topical medication should be utilized at a time unless otherwise directed by a healthcare professional.

Patients should discontinue use and consult a doctor if they experience excessive skin irritation or increased sensitivity. Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is recommended. The product is flammable and should be kept away from fire or flame.

Drug Interactions

Concurrent use of other topical acne medications may enhance the risk of skin dryness or irritation when used simultaneously or immediately after the application of this product. It is advised that only one topical acne treatment be utilized at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Exuviance Daily Acne Peel (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is recommended.

For new users, the product should be applied sparingly with a pad to 1 or 2 small affected areas for approximately 3 days. If no discomfort occurs during this initial application period, patients may then follow the standard usage directions.

Geriatric Use

There is no specific information regarding the use of Exuviance Daily Acne Peel in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be applicable to elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

The use of this medication is contraindicated in pregnant patients and those who are lactating. There is insufficient data to assess the potential risks associated with the use of this medication during pregnancy. Given the lack of safety information, healthcare professionals should advise women of childbearing potential to avoid this medication if they are pregnant or planning to become pregnant. It is essential to consider alternative treatment options that have established safety profiles in this population.

Lactation

Lactating mothers are advised against the use of this medication during breastfeeding. There is no available data on the excretion of the drug in human breast milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a poison control center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

The use of this product is contraindicated during pregnancy and lactation.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a poison control center immediately.

It is important to inform patients that the product is flammable and should be kept away from fire or flame. Additionally, healthcare providers should counsel patients against using this product during pregnancy or while breastfeeding.

Patients should be cautioned to avoid contact with the eyes. In the event of contact, they should rinse the eyes with water to remove the product. Healthcare providers should also instruct patients to discontinue use and consult a doctor if they experience excessive skin irritation or sensitivity that develops or worsens.

Furthermore, when using this product, patients should be made aware that using other topical acne medications simultaneously or immediately after may increase skin dryness or irritation. Only one topical acne medication should be used at a time unless otherwise directed by a healthcare professional.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15°C to 30°C (59°F to 86°F) to maintain its efficacy and stability. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature limits to prevent degradation.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area using a cotton pad 1 to 3 times daily, while avoiding the eye area. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a clinician. If patients experience bothersome peeling or dryness, they should reduce the frequency to once daily or every other day. New users are advised to apply the product sparingly to one or two small affected areas for approximately three days.

Clinicians should counsel patients to avoid sun exposure and to use sunscreen daily. Additionally, patients should wash their hands after application to prevent unintended contact with other areas.

Drug Information (PDF)

This file contains official product information for Exuviance Daily Acne Peel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)